Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.

被引:72
作者
Cao, SG
Foster, C
Brisson, M
Lazo, JS
Kingston, DGI
机构
[1] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA
[2] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA
关键词
Cdc25; natural products; quinones;
D O I
10.1016/j.bmc.2004.11.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Separation of an extract of a Xestospongia sp., guided by bioassay against Cdc25B, led to the isolation of nine compounds, halenaquinone (1), xestoquinone (2), adociaquinones A (3) and B (4), 3-ketoadociaquinones A (5) and B (6), tetrahydrohalenaquinones A (7) and B (8), and 13-O-methyl xestoquinol sulfate (9). The structures of the new natural products 6 and 9 were established on the basis of extensive one- and two-dimensional NMR studies. Compounds 1, 4, and 6 inhibited recombinant human Cdc25B in vitro with IC50 values of 0.7, 0.07, and 0.2 muM, respectively, and were 19- to 150-fold less active against two related protein phosphatases. Compound 4 blocked cell cycle progression through mitosis. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:999 / 1003
页数:5
相关论文
共 32 条
  • [1] PROTEIN-TYROSINE KINASE INHIBITORY PROPERTIES OF PLANAR POLYCYCLICS OBTAINED FROM THE MARINE SPONGE XESTOSPONGIA CF CARBONARIA AND FROM TOTAL SYNTHESIS
    ALVI, KA
    RODRIGUEZ, J
    DIAZ, MC
    MORETTI, R
    WILHELM, RS
    LEE, RH
    SLATE, DL
    CREWS, P
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (18) : 4871 - 4880
  • [2] INHIBITION OF MAMMALIAN TOPOISOMERASE-I BY XESTOQUINONE AND HALENAQUINONE
    BAE, MA
    TSUJI, T
    KONDO, K
    HIRASE, T
    ISHIBASHI, M
    SHIGEMORI, H
    KOBAYASHI, J
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1993, 57 (02) : 330 - 331
  • [3] BARATTE B, 1992, ANTICANCER RES, V12, P873
  • [4] The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase α is mediated by hydrogen peroxide
    Bova, MP
    Mattson, MN
    Vasile, S
    Tam, D
    Holsinger, L
    Bremer, M
    Hui, T
    McMahon, G
    Rice, A
    Fukuto, JM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 429 (01) : 30 - 41
  • [5] Solid-phase synthesis of dysidiolide-derived protein phosphatase inhibitors
    Brohm, D
    Philippe, N
    Metzger, S
    Bhargava, A
    Müller, O
    Lieb, F
    Waldmann, H
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (44) : 13171 - 13178
  • [6] TOPOISOMERASE-II-MEDIATED DNA CLEAVAGE BY ADOCIAQUINOMES AND XESTOQUINOMES FROM THE PHILIPPINE SPONGE XESTOSPONGIA SP
    CONCEPCION, GP
    FODERARO, TA
    ELDREDGE, GS
    LOBKOVSKY, E
    CLARDY, J
    BARROWS, LR
    IRELAND, CM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) : 4503 - 4507
  • [7] DIRK B, 2002, ANGEW CHEM INT EDIT, V41, P307
  • [8] THE CDC25 PROTEIN CONTAINS AN INTRINSIC PHOSPHATASE-ACTIVITY
    DUNPHY, WG
    KUMAGAI, A
    [J]. CELL, 1991, 67 (01) : 189 - 196
  • [9] Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells
    Fujiwara, H
    Matsunaga, K
    Saito, M
    Hagiya, S
    Furukawa, KI
    Nakamura, H
    Ohizumi, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (01) : 37 - 45
  • [10] CDC25 PHOSPHATASES AS POTENTIAL HUMAN ONCOGENES
    GALAKTIONOV, K
    LEE, AK
    ECKSTEIN, J
    DRAETTA, G
    MECKLER, J
    LODA, M
    BEACH, D
    [J]. SCIENCE, 1995, 269 (5230) : 1575 - 1577